The anaemia of infection

Bailliere's Best Practice and Research in Clinical Haematology

Volumn 13, Issue 2, 2000, Pages 151-162

  Means Jr, Robert T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anaemia; Cytokines; Erythropoietin; Ferrokinetics; Host defence; Infection; Iron

Indexed keywords

AMINOSALICYLIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CHLOROQUINE; CIPROFLOXACIN; CYCLOSERINE; CYTOKINE; DAPSONE; FERROUS SULFATE; IRON; ISONIAZID; NIRIDAZOLE; NITROFURAL; NITROFURANTOIN; PRIMAQUINE; PYRAZINAMIDE; PYRIMETHAMINE; RECOMBINANT ERYTHROPOIETIN; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; THIAMPHENICOL; TRIMETHOPRIM; TRIMETREXATE; UNINDEXED DRUG; ZIDOVUDINE;

ANEMIA; ARTICLE; BACTERIAL INFECTION; CHRONIC DISEASE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; ERYTHROPHAGOCYTOSIS; ERYTHROPOIESIS; HOST RESISTANCE; HUMAN; HYPERTENSION; IMMUNOTHERAPY; IRON BLOOD LEVEL; IRON METABOLISM; IRON STORAGE; IRON THERAPY; MEAN CORPUSCULAR HEMOGLOBIN; MYCOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEIZURE; SYNDROME; VIRUS INFECTION;

EID: 0033692689     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.1999.0065     Document Type: Article

References (98)

1. The anemia of infection. XVII. A review
2. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
3. Haematological and iron-related measurements in active pulmonary tuberculosis
4. The haematological and biochemical changes in severe pulmonary tuberculosis
5. Miliary tuberculosis: Rapid diagnosis, hematologic abnormalities, and outcome in 109 American adults
6. Extrapulmonary tuberculosis: Experience in a community hospital and review of the literature
7. Infective endocarditis: Review of 135 cases over 9 years
8. Pneumococcal vertebral osteomyelitis
9. Anemia in children with acute infections seen in a primary care pediatric outpatient clinic
10. The anemia of chronic disease
11. The spectrum of diseases associated with the anemia of chronic disease: A study of 90 cases
12. The pathogenesis of anemia in rheumatoid arthritis. A clinical and laboratory analysis
13. Serum soluble transferrin receptor and the prediction of marrow aspirate results in a heterogeneous group of patients
14. Serum transferrin receptor levels in patients undergoing evaluation of iron stores: Correlation with other parameters, and observed versus predicted results
15. Regulation of transferrin receptors by iron in human erythroblasts
16. Decreased affinity and number of transferrin receptors on erythroblasts in the anemia of rheumatoid arthritis
17. Intact transferrin receptors in human plasma and their relation to erythropoiesis
18. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia
19. Some observations on anemia in rheumatoid arthritis
20. Blunted erythropoietin response to anaemia in tuberculosis
21. Malaria elicits type I cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes
22. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated plasmodium falciparum malaria
23. Radioimmunoassay of tumor necrosis factor in serum
24. Role of tumor necrosis factor in the illness and pathology of malaria
25. The anemia of chronic disease
26. Progress in understanding the pathogenesis of the anemia of chronic disease
27. The role of interleukin I, erythropoietin, and red cell bound immunoglobulins in the anaemia of rheumatoid arthritis
28. Cachectin/tumor necrosis factor alters red blood cell kinetics and induces anemia in vivo
29. Neoctyoloysis contributes to the anemia of renal disease
30. Plasma erythropietin in health and disease
31. Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia
32. Impaired erythropoietin response to anemia after bone marrow transplantation
33. Blunted erythropoietin response to anaemia in rheumatoid arthritis
34. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
35. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
36. Mechanism of anaemia in rheumatoid arthritis: Demonstration of raised interleukin Iβ concentration in anaemic patients and of interleukin I erythroleukemia (HEL) cells in vitro
37. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
38. Tumor necrosis factor-alpha and hematopoietic progenitors: Effects of tumour necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, HEL cells
39. In vivo suppression of erythropoiesis by tumor necrosis factor-α (TNF-α): Reversal with exogenous erythropoietin (EPO)
40. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice
41. Anaemia in rheumatoid arthritis: Role of cytokines
42. In vivo hematopoietic effect of recombinant interleukin-Iα in mice: Stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors; suppression of late stage erythropoiesis, and suppression with erythropoietin
43. Suppression of normal human erythropoiesis by gamma interferon in vitro: Role of monocytes and T-lymphocytes
44. Studies of interferon as a regulator of hematopoietic cell proliferation
45. In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection
46. Immunological aspects of the anemia of rheumatoid arthritis
47. Inhibition of human colony-forming units erythroid by tumor necrosis factor requires accessory cells
48. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon
49. Inhibition of human erythroid colony-forming units by interleukin-I is mediated by gamma interferon
50. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin
51. Inhibition of human erythroid colony-forming units by interferons α and β: Differing mechanisms despite shared receptor
52. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis
53. Inhibition of human erythroid colony formation by ceramide
54. + human bone marrow cells
55. Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells
56. Effect of induced fever on serum iron and ferritin concentrations in man
57. Relationship of trace metals to fever during infection are prostaglandins involved?
58. Serum zinc, iron, and copper concentrations during typhoid fever in man: Effect of chloramphenicol therapy
59. Iron status in children undergoing tonsillectomy and its short term modification following surgery
60. Effect of a mild infection on serum ferritin concentration - Clinical and epidemiological implications
61. Serum ferritin during infection. A longitudinal study in renal transplant patients
62. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor
63. The role of cytokines in the regulation of ferritin expression
64. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relation to cell surface receptors
65. The etiology of the anemia of chronic disease and infection
66. The significance of iron in infection
67. Rapid drop in serum iron concentration as a host defense mechanism. A review of experimental and clinical evidence
68. Transferrin in disease II: Defects in the regulation of transferrin saturation with iron contribute to susceptibility to infection
69. Hyperferremia in immunosuppressed patients with acute nonlymphocytic leukemia and the risk of infection
70. Iron metabolism and fungal infections in patients with haematological malignancies
71. Anemia of chronic disease: A misnomer
72. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
73. Toxic effects on erythrogenesis
74. Hematologic complications of antiinfectious agents
75. Studies in anemia and plasma protein disturbance
76. Repeated therapy with monoclonal antibody to tumour necrosis factor Alpha (cA2) in patients with rheumatoid arthritis
77. Inhibition of murine erythroid colony formation in vitro by gamma interferon and correction by interferon inhibitor
78. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock - NORASEPT II study group
79. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis - A randomized, clinical trial
80. Clinical application of recombinant human erythropoietin in the anemia of chronic disease
81. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis
82. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial
83. Clinical use of the total dose intravenous infusion of iron dextran
84. Annotation: Paroxysmal cold haemoglobinuria
85. Infection
86. Hematological aspects of acute viral hepatitis
87. Clostridial bacteremia in cancer patients. A 12-year experience
88. Hemolytic anemia in a patient with subacute bacterial endocarditis due to Streptococcus sanguis
89. Hemolytic anemia with positive direct antiglobulin test secondary to spontaneous cytomegalovirus infection in healthy adults
90. Hemolytic anemia associated with leptospirosis. Morphologic and lipid studies
91. Hemolytic anemia following postnatally acquired rubella during the 1975-1977 rubella epidemic in Japan
92. Pathophysiology of hemolysis in infections with Hemophilus influenzae type b
93. Autoantibodies against triosephosphate isomerase. A possible clue to pathogenesis of hemolytic anemia in infectious mononucleosis
94. Mechanisms of hemolysis and anemia associated with acute antepartum pyelonephritis
95. Severe autoimmune hemolytic anemia associated with pneumococcal bacteremia
96. Microangiopathic hemolytic anemia and severe thrombocytopenia in Brucella infection
97. Hookworm control as a strategy to prevent iron deficiency
98. Serum ferritin, hemoglobin, and Helicobacter pylori infection: A seroepidemiologic survey comprising 2794 Danish adults